Tirbanibulin dihydrochloride
|
T646909-5mg
|
≥99% |
1038395-65-1 |
5mg
|
¥ 650.9
|
期货,请咨询 |
阿拉丁 |
Tirbanibulin dihydrochloride
|
T646909-50mg
|
≥99% |
1038395-65-1 |
50mg
|
¥ 3100.9
|
期货,请咨询 |
阿拉丁 |
Tirbanibulin dihydrochloride
|
T646909-10mg
|
≥99% |
1038395-65-1 |
10mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
Tirbanibulin dihydrochloride
|
T646909-100mg
|
≥99% |
1038395-65-1 |
100mg
|
¥ 5300.9
|
期货,请咨询 |
阿拉丁 |
TRC-766
|
T646862-5mg
|
≥99% |
1810734-44-1 |
5mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
TRC-766
|
T646862-10mg
|
≥99% |
1810734-44-1 |
10mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
(R)-Terazosin
|
T646849-5mg
|
≥99% |
109351-34-0 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
(R)-Terazosin
|
T646849-50mg
|
≥99% |
109351-34-0 |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
(R)-Terazosin
|
T646849-10mg
|
≥99% |
109351-34-0 |
10mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
tcY-NH2 TFA
|
T646845-5mg
|
≥99% |
1262750-73-1 |
5mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
tcY-NH2 TFA
|
T646845-1mg
|
≥99% |
1262750-73-1 |
1mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
Tangshenoside I
|
T646800-5mg
|
≥97% |
117278-74-7 |
5mg
|
¥ 4900.9
|
期货,请咨询 |
阿拉丁 |
Tangshenoside I
|
T646800-1mg
|
≥97% |
117278-74-7 |
1mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
Tangshenoside I
|
T646800-10mg
|
≥97% |
117278-74-7 |
10mg
|
¥ 7900.9
|
期货,请咨询 |
阿拉丁 |
TH1834
|
T646743-5mg
|
≥99% |
2108830-08-4 |
5mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
TH1834
|
T646743-50mg
|
≥99% |
2108830-08-4 |
50mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |
TH1834
|
T646743-10mg
|
≥99% |
2108830-08-4 |
10mg
|
¥ 2900.9
|
期货,请咨询 |
阿拉丁 |
TH1834
|
T646743-100mg
|
≥99% |
2108830-08-4 |
100mg
|
¥ 20500.9
|
期货,请咨询 |
阿拉丁 |
Tapotoclax
|
T646698-5mg
|
≥99% |
1883727-34-1 |
5mg
|
¥ 19500.9
|
期货,请咨询 |
阿拉丁 |
Tapotoclax
|
T646698-1mg
|
≥99% |
1883727-34-1 |
1mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Thiarabine
|
T646680-1mg
|
≥99% |
26599-17-7 |
1mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
Tectol
|
T646663-1mg
|
≥98% |
24449-39-6 |
1mg
|
¥ 1300.9
|
期货,请咨询 |
阿拉丁 |
TIE-2/VEGFR-2 kinase-IN-1
|
T646632-5mg
|
≥99% |
453590-24-4 |
5mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
TIE-2/VEGFR-2 kinase-IN-1
|
T646632-1mg
|
≥99% |
453590-24-4 |
1mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |